title: The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma.
authors.forename: Hae-Sim
authors.initials: HS
authors.lastname: Park
authors.forename: Seung-Hyun
authors.initials: SH
authors.lastname: Kim
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Sampson
authors.forename: Kyung-Wha
authors.initials: KW
authors.lastname: Lee
authors.forename: Choon-Sik
authors.initials: CS
authors.lastname: Park
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy* / Q000235:genetics; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D005819:Genetic Markers; D006682:HLA-DP Antigens / Q000235:genetics*; D059868:HLA-DP beta-Chains; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests
chemical_list: D018927:Anti-Asthmatic Agents; D005819:Genetic Markers; D006682:HLA-DP Antigens; D059868:HLA-DP beta-Chains; C071170:HLA-DPB1 antigen; D020024:Leukotriene Antagonists; D001241:Aspirin